Drug Policy and Evaluation

The ODPRN has conducted multiple studies that have both informed and evaluated the impact of drug policies in Ontario, and more broadly across Canada.  This research includes a wide breadth of work ranging from large drug class reviews to specific rapid response projects resulting from decision makers’ pressing initiatives.

New Research

Geographic variation in the provision of naloxone by pharmacies in Ontario

 Opioid-related overdoses and deaths have become a public health crisis across North America, with approximately 72,600 opioid-related deaths occurring in Canada and the United States in 2018 alone. Importantly, the majority of opioid-related deaths are unintentional and preventable with the time administration of naloxone, an opioid antagonist that quickly and effectively reserves the effects of an opioid overdose. 

In June 2016, the Ontario Government introduced the Ontario Naloxone Program for Pharmacies (ONPP), authorizing community pharmacies across the province to provide naloxone kits to all Ontario residents free of charge. 

The ONPP was modified in March 2018 to: 1) allow pharmacies to distribute intranasal naloxone, and 2) remove the requirement for individuals to present a valid government health card in order to receive a naloxone kit.

This study investigates regional variation in the distribution of naloxone through the ONPP and identifies individual- and public health unit-level determinants of variation.

All Research on Drug Policy and Evaluation

wdt_ID Title Publication Type Date Released Clinical Topic Additional Resources
wdt_ID Title Publication Type Date Released Clinical Topic Additional Resources
1 Low molecular weight heparin Drug Class Review 01 May 2016 Cardiovascular Health Research Summary
2 The influence of socioeconomic status on selection of anticoagulation for atrial fibrillation Journal Article 25 Feb 2016 Cardiovascular Health
3 Impact of the JUPITER trial on statin prescribing for primary prevention Journal Article 12 Aug 2013 Cardiovascular Health
4 Trends in the coprescription of proton pump inhibitors with clopidogrel: An ecological analysis Journal Article 26 Nov 2015 Cardiovascular Health
5 Antipsychotics in the elderly Drug Class Review 01 May 2015 Dementia and Antipsychotics Research Summary
6 Cognitive enhancers for Alzheimer's Disease Drug Class Review 01 Aug 2015 Dementia and Antipsychotics Research Summary
7 Association of a blood glucose test strip quantity-limit policy with patient outcomes: A population-based study Journal Article 07 Nov 2016 Diabetes Research Minute
8 Adherence to prescribing recommendations made on a provincial formulary Journal Article 01 May 2014 Diabetes Research Minute
9 Blood glucose test strips: Options to reduce usage Journal Article 12 Jan 2010 Diabetes Letter to Editor
10 The impact of policies to reduce blood glucose test strip utilization and costs in Canada Journal Article 01 Jun 2015 Diabetes Research Minute
Please note that this report is NOT COMPLETE and is still in progress. Click below if you would like to continue.